Cutaneous Oncology News

CHICAGO — Tumor lymph node dissection likely can be omitted for patients with melanoma who achieve major pathologic response after neoadjuvant immune checkpoint blockade, according to study results presented at ASCO Annual Meeting.

The quality and quantity of ultraviolet B phototherapy sessions for the treatment of atopic dermatitis did not increase the risk of skin cancer development in patients, according to a study.

Almirall and the Centre for Genomic Regulation have entered into a research collaboration to develop and characterize novel preclinical models for the identification of new nonmelanoma skin cancer treatments, according to a press release.

Understanding the types of gene expression profiling available may help practitioners integrate these tools into their practices, according to a study.

Obtaining RNA samples from suspicious lesions via tape stripping was found to be a valid technique for detecting cutaneous malignant melanoma, according to a study.

In honor of Skin Cancer Awareness Month, Healio has compiled the top skin cancer stories published so far in 2023.

Patients with persistent melanoma in situ have shown tumor clearance with imiquimod after surgery, according to a study.

A combination of imiquimod 5% cream, 5-fluorouracil 2% solution and tretinoin 0.1% cream may be an effective chemoprevention option for reducing the incidences of keratinocyte carcinomas for at least 1 year, according to a study.

Topical DNA repair enzymes did not participate in the recovery of damaged skin, characterized by altered genes, following ultraviolet light exposure, according to a study.

Topical photodynamic therapy and methyl aminolevulinate, marketed as Metvix, displayed effectiveness and good cosmetic outcomes in the treatment of basal cell carcinomas following surgery, according to a study.